The U.S. Senate is scheduled to take up debate next week on an embryonic stem cell bill opposed by the White House but also will consider two other stem cell measures the president could sign. The other less-controversial bills would prohibit so-called "fetal farming" for the purpose of harvesting tissue and fund research on adult-derived stem cells.

Related Summaries